ScoreWhy is Rohto Pharmaceutical Co., Ltd. ?
1
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.73%
- Healthy long term growth as Net Sales has grown by an annual rate of 10.38% and Operating profit at 10.94%
- Company has very low debt and has enough cash to service the debt requirements
2
With ROE of 12.52%, it has a expensive valuation with a 1.80 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -10.62%, its profits have risen by 1.4% ; the PEG ratio of the company is 10.3
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Rohto Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to FMCG should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in FMCG)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Rohto Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Rohto Pharmaceutical Co., Ltd.
-11.17%
-0.50
30.45%
Japan Nikkei 225
28.54%
1.14
25.81%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
10.38%
EBIT Growth (5y)
10.94%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
1.02
Tax Ratio
26.88%
Dividend Payout Ratio
26.45%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.17%
ROE (avg)
12.73%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
1.80
EV to EBIT
11.50
EV to EBITDA
8.57
EV to Capital Employed
1.90
EV to Sales
1.43
PEG Ratio
10.29
Dividend Yield
0.03%
ROCE (Latest)
16.49%
ROE (Latest)
12.52%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(HY)
At JPY 164,694 MM has Grown at 19.31%
DEBTORS TURNOVER RATIO(HY)
Highest at 4.81%
NET PROFIT(Q)
Highest at JPY 12,614.96 MM
-8What is not working for the Company
INTEREST(HY)
At JPY 701 MM has Grown at 765.43%
Here's what is working for Rohto Pharmaceutical Co., Ltd.
Net Sales
At JPY 164,694 MM has Grown at 19.31%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Net Profit
Highest at JPY 12,614.96 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (JPY MM)
Debtors Turnover Ratio
Highest at 4.81%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Here's what is not working for Rohto Pharmaceutical Co., Ltd.
Interest
At JPY 701 MM has Grown at 765.43%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
